No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir microbiologystudyBy sharad / July 13, 2024 Antimicrobial Agents and Chemotherapy, Volume 68, Issue 7, July 2024. Source link